+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032

  • PDF Icon

    Report

  • 146 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5820853
Description Jump to:
The global anti-obesity drugs market size reached US$ 2.3 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.2% during 2023-2032.

Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They help reduce cravings and control compulsive eating, especially for sweets and fatty, salty, and high-calorie food products. They can also provide independent health benefits, such as controlling blood pressure, harmful lipid levels, waist circumference, sugar levels and nonalcoholic fatty liver disease (NAFLD) and minimize the risk of major cardiovascular diseases (CVDs) and progression of diabetic kidney disease.

Anti-Obesity Drugs Market Trends:

Recent advances in anti-obesity drugs have enabled the potential of attaining clinically significant weight loss among individuals. This, in confluence with the widespread prevalence of obesity on account of sedentary lifestyles, represents one of the key factors creating a positive outlook for the market. In addition, obesity increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases (CVD), and cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney. It can also result in numerous psychological, neurological, pulmonary, gastrointestinal, renal, musculoskeletal, and endocrine diseases. Besides this, sleep deprivation, circadian desynchronization, chronic stress, and the rising use of anti-epileptic and psychotropic drugs may further induce weight gain. This, coupled with the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings, is fueling the growth of the market. Apart from this, weight loss aids in improving the quality of life, mobility, daily function, and psychological well-being of individuals. This, along with the increasing health consciousness, thriving pharmaceutical industry, and the rising focus on the management of diseases closely integrated with excess body weight, is anticipated to stimulate the growth of the market.

Key Market Segmentation:

The report provides an analysis of the key trends in each sub-segment of the global anti-obesity drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, drug type, and distribution channel.

Breakup by Drug Class:

Peripherally Acting Drugs
Centrally Acting Drugs

Breakup by Drug Type:

Prescription Drugs
OTC Drugs

Breakup by Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Currax Pharmaceuticals LLC, Gelesis, GlaxoSmithKline plc, Merck & Co. Inc., Norgine B.V., Novo Nordisk A/S, Pfizer Inc., Rhythm Pharmaceuticals Inc., SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Vivus LLC.

Key Questions Answered in This Report

1. What was the size of the global anti-obesity drugs market in 2023?
2. What is the expected growth rate of the global anti-obesity drugs market during 2024-2032?
3. What are the key factors driving the global anti-obesity drugs market?
4. What has been the impact of COVID-19 on the global anti-obesity drugs market?
5. What is the breakup of the global anti-obesity drugs market based on the drug class?
6. What is the breakup of the global anti-obesity drugs market based on the drug type?
7. What is the breakup of the global anti-obesity drugs market based on distribution channel?
8. What are the key regions in the global anti-obesity drugs market?
9. Who are the key players/companies in the global anti-obesity drugs market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Anti-Obesity Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Peripherally Acting Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Centrally Acting Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Prescription Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 OTC Drugs
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Boehringer Ingelheim International GmbH
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Currax Pharmaceuticals LLC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Gelesis
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 GlaxoSmithKline plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Merck & Co. Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Norgine B.V.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Novo Nordisk A/S
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Rhythm Pharmaceuticals Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 SHIONOGI & Co. Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Vivus LLC
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Anti-Obesity Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Anti-Obesity Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Anti-Obesity Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Anti-Obesity Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Anti-Obesity Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Anti-Obesity Drugs (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Anti-Obesity Drugs (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: North America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: North America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: United States: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: United States: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Canada: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Canada: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Asia-Pacific: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Asia-Pacific: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Japan: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: South Korea: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: South Korea: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Australia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Australia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Indonesia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Indonesia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Germany: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Germany: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: France: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: France: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United Kingdom: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United Kingdom: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Italy: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Italy: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Spain: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Spain: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Russia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Russia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Latin America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Latin America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Brazil: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Brazil: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Mexico: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Mexico: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Middle East and Africa: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Middle East and Africa: Anti-Obesity Drugs Market: Breakup by Country (in %), 2023
Figure 70: Middle East and Africa: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: Anti-Obesity Drugs Industry: SWOT Analysis
Figure 72: Global: Anti-Obesity Drugs Industry: Value Chain Analysis
Figure 73: Global: Anti-Obesity Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Anti-Obesity Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Anti-Obesity Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Anti-Obesity Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Anti-Obesity Drugs Market: Competitive Structure
Table 7: Global: Anti-Obesity Drugs Market: Key Players

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Currax Pharmaceuticals LLC
  • Gelesis
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Norgine B.V.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Rhythm Pharmaceuticals Inc.
  • SHIONOGI & Co. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Vivus LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages146
PublishedJuly 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 2.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.5 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Anti-obesity Drugs Market Report 2024-2034 - Product Image

Anti-obesity Drugs Market Report 2024-2034

  • Report
  • 310 Pages
  • Global
From
North America Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029 - Product Image

North America Anti-Obesity Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Mechanism of Action, By Route Of Administration (Oral Route and Subcutaneous Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

  • Report
  • 72 Pages
  • North America
From
Asia Pacific Anti-Obesity Drugs Market Report and Forecast 2024-2032 - Product Image

Asia Pacific Anti-Obesity Drugs Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Asia Pacific
From
Anti-Obesity Drugs - Global Strategic Business Report - Product Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • 264 Pages
  • Global
From
Anti-Obesity Drugs Market Report and Forecast 2024-2032 - Product Image

Anti-Obesity Drugs Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.